Related references
Note: Only part of the references are listed.Time for a Fully Integrated Nonclinical-Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective
Hugo M. Vargas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
In vivo comparison of dl-sotalol-induced electrocardiographic responses among halothane anesthesia, isoflurane anesthesia with nitrous oxide, and conscious state
Hiroyuki Saito et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2021)
Evaluation of the Effect of 5 QT-Positive Drugs on the JTpeak Interval - An Analysis of ECGs From the IQ-CSRC Study
Borje Darpo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy
Zhihua Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular Repolarization
Jorg Taubel et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Evolution of Electrocardiographic Repolarization Parameters During Antiandrogen Therapy in Patients with Prostate Cancer and Hypogonadism
Andrei Cristian Dan Gheorghe et al.
CARDIOVASCULAR TOXICOLOGY (2020)
Improving prediction of torsadogenic risk in the CiPA in silico model by appropriately accounting for clinical exposure
Derek J. Leishman
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm
Bradley J. Ridder et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
First Clinical Study with AP30663-a KCa2 Channel Inhibitor in Development for Conversion of Atrial Fibrillation
Pim Gal et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
A general procedure to select calibration drugs for lab-specific validation and calibration of proarrhythmia risk prediction models: An illustrative example using the CiPA model
Xiaomei Han et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Revisiting the hERG safety margin after 20 years of routine hERG screening
Derek J. Leishman et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2020)
Confounders and Pharmacological Characterization When Using the QT, JTp, and Tpe Intervals in Beagle Dogs
Emmanuel Boulay et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2020)
Identification of Drug-Induced Multichannel Block and Proarrhythmic Risk in Humans Using Continuous T Vector Velocity Effect Profiles Derived From Surface Electrocardiograms
Werner Bystricky et al.
FRONTIERS IN PHYSIOLOGY (2020)
Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block
Phu N. Tran et al.
PLOS ONE (2020)
Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations
Gary Gintant et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
Zhihua Li et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
The Potential Role of the J-Tpeak Interval in Proarrhythmic Cardiac Safety: Current State of the Science From the American College of Clinical Pharmacology and the Cardiac Safety Research Consortium
Jose Vicente et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study
Esther D. Kim et al.
BMC NEPHROLOGY (2019)
Detection of T Wave Peak for Serial Comparisons of JTp Interval
Katerina Hnatkova et al.
FRONTIERS IN PHYSIOLOGY (2019)
Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA Meeting
David G. Strauss et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2019)
T vector velocity distribution: A new biomarker for identifying drug effects on cardiac myocyte ion channels
Werner Bystricky et al.
JOURNAL OF ELECTROCARDIOLOGY (2019)
Heart Rate Correction of the J-to-Tpeak Interval
Katerina Hnatkova et al.
SCIENTIFIC REPORTS (2019)
Discrimination of the effects of three cardiac ion channel blockers using ECG biomarkers and arrhythmia incidence in St. Kitts green monkeys (Chlorocebus Sabaeus)
Bob Brockwaya et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2019)
Comparison of effects of moxifloxacin on QT, JTpeak and Tpe in conscious telemetered dogs and nonhuman primates
Todd Wisialowski et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2019)
Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study
Jose Vicente et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored Consortium
Emmanuel Boulay et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2019)
The Cardiovascular Effects of a Meal: J-Tpeak and Tpeak-Tend Assessment and Further Insights Into the Physiological Effects
Jorg Taubel et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block
Jakub Tomek et al.
ELIFE (2019)
Can non-clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium
Eunjung Park et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Effects of moxifloxacin on the proarrhythmic surrogate markers in healthy Filipino subjects: Exposure-response modeling using ECG data of thorough QT/QTc study
Suchitra Matsukura et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
The effects of supraphysiological oestrogen levels on ventricular repolarisation parameters
Omer Yiginer et al.
KARDIOLOGIA POLSKA (2018)
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova et al.
CELL REPORTS (2018)
Comparison of Two Highly Automated ECG Algorithms for Detection of Drug-Induced Cardiac Ion Channel Block
Marina Brockway et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the CiPA Initiative and Design of a Prospective Clinical Validation Study
Jose Vicente et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Anti-atrial Fibrillatory Versus Proarrhythmic Potentials of Amiodarone: A New Protocol for Safety Evaluation In Vivo
Suchitra Matsukura et al.
CARDIOVASCULAR TOXICOLOGY (2017)
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Ksenia Blinova et al.
TOXICOLOGICAL SCIENCES (2017)
An evaluation of multiple algorithms for the measurement of the heart rate corrected JTpeak interval
Jean-Philippe Couderc et al.
JOURNAL OF ELECTROCARDIOLOGY (2017)
An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data
Christopher E. Pollard et al.
TOXICOLOGICAL SCIENCES (2017)
A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
Hiroyuki Ando et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
Uncertainty Quantification Reveals the Importance of Data Variability and Experimental Design Considerations for in Silico Proarrhythmia Risk Assessment
Kelly C. Chang et al.
FRONTIERS IN PHYSIOLOGY (2017)
Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
Sara Dutta et al.
FRONTIERS IN PHYSIOLOGY (2017)
Improving the In Silico Assessment of Proarrhythmia Risk by Combining hERG (Human Ether-a-go-go-Related Gene) Channel-Drug Binding Kinetics and Multichannel Pharmacology
Zhihua Li et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2017)
Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR
Jonathan P. Piccini et al.
HEART RHYTHM (2016)
Quantitative Profiling of the Effects of Vanoxerine on Human Cardiac Ion Channels and its Application to Cardiac Risk
Carlos A. Obejero-Paz et al.
SCIENTIFIC REPORTS (2015)
Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
L. Johannesen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative
Lorna Ewart et al.
TOXICOLOGICAL SCIENCES (2014)
MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes
James Kramer et al.
SCIENTIFIC REPORTS (2013)
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk
Gary R. Mirams et al.
CARDIOVASCULAR RESEARCH (2011)
An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation
Gary Gintant
PHARMACOLOGY & THERAPEUTICS (2011)
Integrated risk assessment and predictive value to humans of non-clinical repolarization assays
Robert M. Wallis
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts
A. Sugiyama
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine
Lin Wu et al.
HEART RHYTHM (2008)
Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone
Lin Wu et al.
CARDIOVASCULAR RESEARCH (2008)
State dependent dissociation of HERG channel inhibitors
D. Stork et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
L-type calcium current reactivation contributes to arrhythmogenesis associated with action potential triangulation
Donglin Guo et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2007)
Prediction of the risk of Torsade de Pointes using the model of isolated canine Purkinje fibres
P Champeroux et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Dynamic beat-to-beat Modeling of the QT-RR interval relationship: Analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition
AA Fossa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
QT PRODACT: In vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals
S Toyoshima et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
QT PRODACT: In vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation
K Ando et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2005)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
Share Paper
